Home/Filings/4/0001567619-22-012912
4//SEC Filing

Kristal Robert Eugene 4

Accession 0001567619-22-012912

CIK 0001505497other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:50 PM ET

Size

5.9 KB

Accession

0001567619-22-012912

Insider Transaction Report

Form 4
Period: 2022-06-15
Kristal Robert Eugene
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-06-15$3.61/sh+194$7007,994 total
Holdings
  • Stock Option

    Exercise: $13.50Exp: 2031-11-04Common Stock (10,490 underlying)
    10,490
Footnotes (1)
  • [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1
  • filerCIK 0001893955

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:50 PM ET
Size
5.9 KB